Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN)

被引:0
作者
Jinlei Li
Alex Smith
Simon Crouch
Steven Oliver
Eve Roman
机构
[1] University of York,Department of Health Sciences
[2] Peking Union Medical College,undefined
来源
Cancer Causes & Control | 2016年 / 27卷
关键词
Prevalence; Cancer registry; Epidemiology; Leukemia; Lymphoma; Myeloma;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1019 / 1026
页数:7
相关论文
共 83 条
[1]  
Capocaccia R(2002)Measuring cancer prevalence in Europe: the EUROPREVAL project Ann Oncol Off J Eur Soc Med Oncol ESMO 13 831-839
[2]  
Colonna M(2003)Cancer prevalence in the UK: results from the EUROPREVAL study Ann Oncol Off J Eur Soc Med Oncol ESMO 14 648-654
[3]  
Corazziari I(2003)Cancer prevalence in Northern Europe: the EUROPREVAL study Ann Oncol Off J Eur Soc Med Oncol ESMO 14 946-957
[4]  
De Angelis R(2000)Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program Int J Epidemiol 29 197-207
[5]  
Francisci S(2003)Cancer prevalence in Central Europe: the EUROPREVAL Study Ann Oncol Off J Eur Soc Med Oncol ESMO 14 313-322
[6]  
Micheli A(2002)A comparative analysis of cancer prevalence in cancer registry areas of France, Italy and Spain Ann Oncol Off J Eur Soc Med Oncol ESMO 13 1128-1139
[7]  
Forman D(2010)Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer J Int Cancer 127 2893-2917
[8]  
Stockton D(2010)The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research Br J Haematol 148 739-753
[9]  
Møller H(1997)Estimating the completeness of prevalence based on cancer registry data Stat Med 16 425-440
[10]  
Quinn M(2006)Estimating the variance of cancer prevalence from population-based registries Stat Methods Med Res 15 235-253